Although the validity of this conclusion awaits further authentication in animal models, this newly identified role for SPON2 certainly renews the argument that SPON2 neutralization by targeting Egr-1/BRG1 may be a reasonable approach when devising interventional strategies against atherosclerosis. Here, SPON2 is linked to atherosclerosis.